3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide

C₁₅₈H₂₂₀ClFN₃₄O₂₀ — CID 157225996

About 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide

3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide (PubChem CID 157225996) has the molecular formula C₁₅₈H₂₂₀ClFN₃₄O₂₀ and a molecular weight of 2970.17 g/mol. Its IUPAC name is 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide.

Molecular Properties

• Compound Name: 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide
• PubChem CID: 157225996
• Molecular Formula: C₁₅₈H₂₂₀ClFN₃₄O₂₀
• Molecular Weight: 2970.17 g/mol
• Exact Mass: 2967.69
• IUPAC Name: 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide
• SMILES: CC(C)(CC(=O)C1CNCCOC1)c1ncc2c(Cl)cccn12.CC1CC=Cn2c1cnc2C(C)(C)NC(=O)C1CNCCOC1.COc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)ncc12.Cc1cc(C)c2cnc(C(C)(C)NC(=O)C3CNCCOC3)n2c1.Cc1cccn2c(C(C)(C)NC(=O)C3CCNCCO3)ncc12.Cc1cccn2c(C(C)(CC(C)C)NC(=O)[C@@H]3CNCCO3)ncc12.Cc1cccn2c(C3(NC(=O)[C@@H]4CNCCO4)CCOC3)ncc12.Cc1nc(C(C)(C)CC(=O)[C@@H]2CNCCO2)c2cccc(C)c2n1.Cc1nc(C(C)(C)NC(=O)C2CNCCOC2)n2cccc(F)c12
• InChI: InChI=1S/C19H28N4O2.C19H25N3O2.C18H26N4O2.C17H22ClN3O2.C17H23FN4O2.C17H22N4O3.C17H24N4O3.C17H24N4O2.C17H26N4O2/c1-13(2)10-19(4,22-17(24)16-12-20-7-9-25-16)18-21-11-15-14(3)6-5-8-23(15)18;1-12-6-5-7-14-17(12)21-13(2)22-18(14)19(3,4)10-15(23)16-11-20-8-9-24-16;1-12-7-13(2)15-9-20-17(22(15)10-12)18(3,4)21-16(23)14-8-19-5-6-24-11-14;1-17(2,8-15(22)12-9-19-5-7-23-11-12)16-20-10-14-13(18)4-3-6-21(14)16;1-11-14-13(18)5-4-7-22(14)16(20-11)17(2,3)21-15(23)12-9-19-6-8-24-10-12;1-12-3-2-6-21-13(12)9-19-16(21)17(4-7-23-11-17)20-15(22)14-10-18-5-8-24-14;1-17(2,20-15(22)12-9-18-6-8-24-11-12)16-19-10-13-14(23-3)5-4-7-21(13)16;1-12-5-4-9-21-13(12)11-19-16(21)17(2,3)20-15(22)14-6-7-18-8-10-23-14;1-12-5-4-7-21-14(12)10-19-16(21)17(2,3)20-15(22)13-9-18-6-8-23-11-13/h5-6,8,11,13,16,20H,7,9-10,12H2,1-4H3,(H,22,24);5-7,16,20H,8-11H2,1-4H3;7,9-10,14,19H,5-6,8,11H2,1-4H3,(H,21,23);3-4,6,10,12,19H,5,7-9,11H2,1-2H3;4-5,7,12,19H,6,8-10H2,1-3H3,(H,21,23);2-3,6,9,14,18H,4-5,7-8,10-11H2,1H3,(H,20,22);4-5,7,10,12,18H,6,8-9,11H2,1-3H3,(H,20,22);4-5,9,11,14,18H,6-8,10H2,1-3H3,(H,20,22);4,7,10,12-13,18H,5-6,8-9,11H2,1-3H3,(H,20,22)/t16-,19?;16-;;;;14-,17?;;;/m00...0.../s1
• InChIKey: ATNTYESLDHZFPN-YPMXMAMSSA-N
• XLogP: 13.96
• TPSA: 612.34 Ų
• H-Bond Donors: 16
• H-Bond Acceptors: 47
• Rotatable Bonds: 32
• Heavy Atoms: 214
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2970.17
LogP ≤ 5	13.96
H-Bond Donors ≤ 5	16
H-Bond Acceptors ≤ 10	47

Frequently Asked Questions

What is the IUPAC name of 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide?

The IUPAC name of 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide (CID 157225996) is 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide.

What is the SMILES notation for 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide?

The canonical SMILES for 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide is CC(C)(CC(=O)C1CNCCOC1)c1ncc2c(Cl)cccn12.CC1CC=Cn2c1cnc2C(C)(C)NC(=O)C1CNCCOC1.COc1cccn2c(C(C)(C)NC(=O)C3CNCCOC3)ncc12.Cc1cc(C)c2cnc(C(C)(C)NC(=O)C3CNCCOC3)n2c1.Cc1cccn2c(C(C)(C)NC(=O)C3CCNCCO3)ncc12.Cc1cccn2c(C(C)(CC(C)C)NC(=O)[C@@H]3CNCCO3)ncc12.Cc1cccn2c(C3(NC(=O)[C@@H]4CNCCO4)CCOC3)ncc12.Cc1nc(C(C)(C)CC(=O)[C@@H]2CNCCO2)c2cccc(C)c2n1.Cc1nc(C(C)(C)NC(=O)C2CNCCOC2)n2cccc(F)c12.

What is the InChIKey of 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide?

The InChIKey is ATNTYESLDHZFPN-YPMXMAMSSA-N. The full InChI is InChI=1S/C19H28N4O2.C19H25N3O2.C18H26N4O2.C17H22ClN3O2.C17H23FN4O2.C17H22N4O3.C17H24N4O3.C17H24N4O2.C17H26N4O2/c1-13(2)10-19(4,22-17(24)16-12-20-7-9-25-16)18-21-11-15-14(3)6-5-8-23(15)18;1-12-6-5-7-14-17(12)21-13(2)22-18(14)19(3,4)10-15(23)16-11-20-8-9-24-16;1-12-7-13(2)15-9-20-17(22(15)10-12)18(3,4)21-16(23)14-8-19-5-6-24-11-14;1-17(2,8-15(22)12-9-19-5-7-23-11-12)16-20-10-14-13(18)4-3-6-21(14)16;1-11-14-13(18)5-4-7-22(14)16(20-11)17(2,3)21-15(23)12-9-19-6-8-24-10-12;1-12-3-2-6-21-13(12)9-19-16(21)17(4-7-23-11-17)20-15(22)14-10-18-5-8-24-14;1-17(2,20-15(22)12-9-18-6-8-24-11-12)16-19-10-13-14(23-3)5-4-7-21(13)16;1-12-5-4-9-21-13(12)11-19-16(21)17(2,3)20-15(22)14-6-7-18-8-10-23-14;1-12-5-4-7-21-14(12)10-19-16(21)17(2,3)20-15(22)13-9-18-6-8-23-11-13/h5-6,8,11,13,16,20H,7,9-10,12H2,1-4H3,(H,22,24);5-7,16,20H,8-11H2,1-4H3;7,9-10,14,19H,5-6,8,11H2,1-4H3,(H,21,23);3-4,6,10,12,19H,5,7-9,11H2,1-2H3;4-5,7,12,19H,6,8-10H2,1-3H3,(H,21,23);2-3,6,9,14,18H,4-5,7-8,10-11H2,1H3,(H,20,22);4-5,7,10,12,18H,6,8-9,11H2,1-3H3,(H,20,22);4-5,9,11,14,18H,6-8,10H2,1-3H3,(H,20,22);4,7,10,12-13,18H,5-6,8-9,11H2,1-3H3,(H,20,22)/t16-,19?;16-;;;;14-,17?;;;/m00...0.../s1.

What are the key properties of 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide?

3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide has a molecular weight of 2970.17 g/mol, XLogP of 13.96, 32 rotatable bonds, 16 hydrogen bond donors, and 47 hydrogen bond acceptors.

Where does this data come from?

All data for 3-(8-chloroimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(1,4-oxazepan-6-yl)butan-1-one;N-[2-(6,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;3-(2,8-dimethylquinazolin-4-yl)-3-methyl-1-[(2S)-morpholin-2-yl]butan-1-one;N-[2-(8-fluoro-1-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methyl-7,8-dihydroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;(2S)-N-[4-methyl-2-(8-methylimidazo[1,5-a]pyridin-3-yl)pentan-2-yl]morpholine-2-carboxamide is sourced from PubChem (CID 157225996), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Sources

• PubChem CID 157225996 — identifiers, structure, computed properties (public domain)

How this page is built: methodology · editorial policy & corrections.